6,11-Dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid, 97.0%, 5g

2,7-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 97%, 250mg

5-Chloro-6-(chloromethyl)pyrimidine-2,4(1H,3H)-dione, 95.0%, 25g

(S)-2-Nitro-6-((4-(trifluoromethoxy)benzyl)oxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, 95.0%, 100mg

2-(2-Hydroxycyclohexyl)phenol (cis- and trans- mixture, predominantly cis-isomer)>98.0%(GC)1g

4-Acetoxy-3',4'-dimethoxybenzophenone, 90.0%, 1g

5-Methyl-4-nitro-3-trifluoromethyl-1H-pyrazole, 95.0%, 10g

Ethyl 6-((tert-butoxycarbonyl)amino)spiro[3.3]heptane-2-carboxylate, 95.0%, 250mg

(S)-2-Amino-2-(2-methoxypyridin-4-yl)ethanol dihydrochloride, 97.0%, 100mg

2-hydrazinyl-4-methyl-6-(propan-2-yloxy)pyrimidine, 95.0%, 500mg

1-(4-bromobenzoyl)-3-methylpiperazine, 95.0%, 1g

(1S)-3,3'-Bis(4-nitrophenyl)[1,1'-binaphthalene]-2,2'-diol, ��97.0%, 250mg

9-Methylacridine>97.0%(GC)5g